L

Lionco Pharmaceutical Group Co Ltd
SSE:603669

Watchlist Manager
Lionco Pharmaceutical Group Co Ltd
SSE:603669
Watchlist
Price: 4.71 CNY -2.08%
Market Cap: 3.4B CNY

Relative Value

The Relative Value of one Lionco Pharmaceutical Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 4.71 CNY, Lionco Pharmaceutical Group Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Lionco Pharmaceutical Group Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
69
vs Industry
12
Median 3Y
14.7
Median 5Y
10.2
Industry
2.6
vs History
vs Industry
Median 3Y
-25.9
Median 5Y
-18.4
Industry
21.7
vs History
vs Industry
Median 3Y
-37.3
Median 5Y
-30.1
Industry
16.6
vs History
vs Industry
4
Median 3Y
-11.3
Median 5Y
-9.9
Industry
22.5
vs History
20
vs Industry
20
Median 3Y
3.9
Median 5Y
4
Industry
2.3
vs History
65
vs Industry
12
Median 3Y
13.7
Median 5Y
10.1
Industry
2.9
vs History
57
vs Industry
7
Median 3Y
29.6
Median 5Y
20.6
Industry
5.5
vs History
vs Industry
Median 3Y
-31.3
Median 5Y
-17.9
Industry
13.1
vs History
vs Industry
Median 3Y
-31.3
Median 5Y
-17.9
Industry
16.6
vs History
vs Industry
Median 3Y
-37.5
Median 5Y
-28.4
Industry
15.8
vs History
vs Industry
Median 3Y
-34.8
Median 5Y
-22.3
Industry
19.1
vs History
96
vs Industry
21
Median 3Y
4.1
Median 5Y
4.4
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Lionco Pharmaceutical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Lionco Pharmaceutical Group Co Ltd
SSE:603669
3.4B CNY 7.9 -28.7 -43.5 -43.5
US
Eli Lilly and Co
NYSE:LLY
954.7B USD 16.1 51.9 34.8 37.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
505.3B USD 5.5 20.1 16.4 21.3
CH
Roche Holding AG
SIX:ROG
252.4B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP 4.9 30.1 108.4 158.7
CH
Novartis AG
SIX:NOVN
203.1B CHF 4.6 17.8 11.3 14.6
US
Merck & Co Inc
NYSE:MRK
245.9B USD 3.8 12.9 9.2 10.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.6 9.5 11.1
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
147.4B USD 2.3 15 7.6 10.4
P/E Multiple
Earnings Growth PEG
CN
L
Lionco Pharmaceutical Group Co Ltd
SSE:603669
Average P/E: 23.5
Negative Multiple: -28.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
51.9
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.1
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.1
38%
0.8
CH
Novartis AG
SIX:NOVN
17.8
17%
1
US
Merck & Co Inc
NYSE:MRK
12.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.6
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
L
Lionco Pharmaceutical Group Co Ltd
SSE:603669
Average EV/EBITDA: 437.6
Negative Multiple: -43.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
34.8
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.3
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.2
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.5
2%
4.8
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
L
Lionco Pharmaceutical Group Co Ltd
SSE:603669
Average EV/EBIT: 1 878.5
Negative Multiple: -43.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.3
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.3
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
14.6
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.9
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.1
1%
11.1
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
8%
1.3